Previous 10 | Next 10 |
2023-12-14 09:10:00 ET Two of the biggest names in healthcare today are Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) . These companies have the most popular weight loss drugs available in the market right now. And that's a key reason why shares of these two companies...
2023-12-13 20:16:43 ET Summary Coatue Management's 13F portfolio value decreased from $20.41B to $19.71B in Q3 2023. The largest five stakes in the portfolio are Nvidia, Meta Platforms, Amazon.com, Advanced Micro Devices, and Microsoft. New stakes include Shopify, Maplebear In...
2023-12-13 13:37:28 ET More on AmWell, Teladoc, etc. Teladoc: High Stock Compensation Is An Issue Teladoc: No Floor Yet Teladoc's Valuation Proposition: 7x EBITDA In 2024, Not So Bad Global telemedicine market to hit $450B in 2032: report American Wel...
2023-12-13 11:29:58 ET The healthcare sector encompasses a wide range of companies involved in medical services, pharmaceuticals, medical equipment, and health insurance. This sector is essential due to its direct impact on human health and well-being. It is known for its resilience, as hea...
2023-12-13 10:34:35 ET More on Eli Lilly: Bubble Warning: Unrealistic Growth Priced In And Multiple Risk Factors For Eli Lilly Eli Lilly and Company (LLY) Presents at 6th Evercore ISI HealthCONx Conference (Transcript) Eli Lilly: Perfectly Priced Healthcare Giant ...
2023-12-12 14:34:38 ET More on Eli Lilly, Novartis, etc. Novartis: Post Investor Day, Higher Guidance Priced In Bubble Warning: Unrealistic Growth Priced In And Multiple Risk Factors For Eli Lilly Eli Lilly and Company (LLY) Presents at 6th Evercore ISI HealthCONx Co...
2023-12-12 12:28:38 ET Summary Significant Upside Potential: Both models project strong growth for Medtronic, with the first indicating a remarkable 130.3% increase and the more conservative second model predicting a compelling 26.7% annual return. Diverse Analytical Approaches: T...
2023-12-12 11:51:20 ET More on Amgen Amgen Inc. (AMGN) Presents at 6th Annual Evercore ISI HealthCONx Conference (Transcript) AbbVie Vs. Amgen: How Peter Lynch Picks Dividend Stocks Amgen: Buy In Stable Fundamental And Technical Price Growth Amazon Web Servic...
2023-12-12 08:00:00 ET Summary Large-cap growth outperformed mid-cap and small-cap growth in 2023 thanks to positive investor sentiment and the surge of the generative AI wave. And large caps are positioned to again outperform in 2024 due to the expected higher-for-longer Fed post...
2023-12-12 07:30:00 ET Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) have been the two best-performing large-cap pharma stocks over the past 10 years. The core reason is their strong competitive positions in type 2 diabetes and obesity care. Lilly's leading metaboli...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 07:07:00 ET If your portfolio doesn't have exposure to the biopharma businesses pursuing the development of weight loss medicines, it might be time to consider changing that situation. With an influx of new drugs for sale, and many competitors looking to secure their share of the...
2024-07-30 05:48:00 ET Going into 2024, DexCom 's (NASDAQ: DXCM) shares were up a whopping 14 times over the last 10 years. The company's continuous glucose monitoring (CGM) devices enjoyed tremendous demand from individuals with diabetes. However, last week was the worst for De...
2024-07-29 15:13:21 ET Eli Lilly & Co (NYSE: LLY) has recently experienced a dramatic $123 billion decline in market value. This significant drop follows positive developments from competitors, notably Viking Therapeutics Inc and Roche Holding AG, who made announcements regarding th...